133 related articles for article (PubMed ID: 1502898)
1. Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
Risteli L; Risteli J; Puistola U; Tomás C; Zhu GG; Kauppila A
Acta Obstet Gynecol Scand Suppl; 1992; 155():99-103. PubMed ID: 1502898
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous evaluation of epithelial cell function by CA 125 and stromal cell activity by aminoterminal propeptide of type III procollagen (PIIINP) in ovarian carcinoma.
Tomás C; Penttinen J; Risteli J; Risteli L; Kauppila A
Ann Med; 1990 Apr; 22(2):115-21. PubMed ID: 2361007
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of CA 125 and aminoterminal propeptide of type III procollagen (PIIINP) in patients with endometrial carcinoma.
Tomás C; Penttinen J; Risteli J; Risteli L; Vuori J; Kauppila A
Cancer; 1990 Dec; 66(11):2399-406. PubMed ID: 2245396
[TBL] [Abstract][Full Text] [Related]
4. Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.
Simojoki M; Santala M; Risteli J; Risteli L; Kauppila A
Anticancer Res; 2000; 20(6C):4655-60. PubMed ID: 11205196
[TBL] [Abstract][Full Text] [Related]
5. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
Puistola U; Risteli L; Risteli J; Kauppila A
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma.
Santala M; Risteli L; Puistola U; Risteli J; Kauppila A
Ann Med; 1995 Feb; 27(1):57-61. PubMed ID: 7742000
[TBL] [Abstract][Full Text] [Related]
7. Effect of gynecological operations on the serum concentration of the aminoterminal propeptide of type III procollagen.
Tomás C; Puistola U; Risteli L; Risteli J; Kauppila A
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):391-5. PubMed ID: 8392273
[TBL] [Abstract][Full Text] [Related]
8. Impact of chemotherapy on collagen metabolism: a study of serum PIIINP (aminoterminal propeptide of type III procollagen) in advanced sarcomas.
Wiklund TA; Blomqvist CP; Risteli L; Risteli J; Elomaa I
J Cancer Res Clin Oncol; 1993; 119(3):160-4. PubMed ID: 8418089
[TBL] [Abstract][Full Text] [Related]
9. Amino-terminal propeptide of type III procollagen: a new prognosis indicator in human ovarian cancer.
Kauppila A; Puistola U; Risteli J; Risteli L
Cancer Res; 1989 Apr; 49(7):1885-9. PubMed ID: 2924328
[TBL] [Abstract][Full Text] [Related]
10. Aminoterminal propeptide of type-III procollagen in serum--an indicator of clinical behavior of advanced ovarian carcinoma?
Risteli L; Kauppila A; Mäkilä UM; Risteli J
Int J Cancer; 1988 Mar; 41(3):409-14. PubMed ID: 3346105
[TBL] [Abstract][Full Text] [Related]
11. Progressive ovarian carcinoma induces synthesis of type I and type III procollagens in the tumor tissue and peritoneal cavity.
Zhu GG; Risteli J; Puistola U; Kauppila A; Risteli L
Cancer Res; 1993 Oct; 53(20):5028-32. PubMed ID: 8402695
[TBL] [Abstract][Full Text] [Related]
12. Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study.
Zhu GG; Stenbäck F; Risteli L; Risteli J; Kauppila A
Cancer; 1993 Sep; 72(5):1679-84. PubMed ID: 8348501
[TBL] [Abstract][Full Text] [Related]
13. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen (PIIINP).
Taube T; Franssila K; Risteli L; Risteli J; Elomaa I
Br J Haematol; 1992 Sep; 82(1):32-7. PubMed ID: 1419800
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of serum aminoterminal propeptide of type III procollagen as tumor marker in gynecologic malignancies.
Abdel Aziz MT; Abdel Aziz Wassef M; Kamel M; el Zein M; el Hassan H
Tumori; 1993 Jun; 79(3):219-23. PubMed ID: 8236508
[TBL] [Abstract][Full Text] [Related]
16. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
20. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Surgery; 1990 Apr; 107(4):381-8. PubMed ID: 2321135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
